Scott J. Rodig
Brigham and Women's Hospital(US)Harvard University(US)Dana-Farber Cancer Institute(US)Dana-Farber Brigham Cancer Center(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Lymphoma Diagnosis and Treatment, Cancer Genomics and Diagnostics, Immunotherapy and Immune Responses
Most-Cited Works
- → PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma(2014)3,521 cited
- → An immunogenic personal neoantigen vaccine for patients with melanoma(2017)2,836 cited
- → Comprehensive analyses of tumor immunity: implications for cancer immunotherapy(2016)2,741 cited
- → Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade(2019)1,974 cited
- → Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes(2018)1,920 cited
- → Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK(2009)1,873 cited